100X Gains On Tap as Under-the-Radar Green-Tech Stock Soars
Searching for the next 1,000% stock winner? Look no further than key Green-Techs that are driving the EV, Solar & 5G booms. Silver is the #1 element in the Green Energy Revolution & we’ve found the top silver gem – undiscovered at 10-cents per share – that’s fueling the path to a carbon-free world.
Get the details here...
pixel

RAPT Insider Trading (RAPT Therapeutics)

Insider Ownership Percentage: 31.00%
Insider Buying (Last 12 Months): $217,191.00
Insider Selling (Last 12 Months): $21,233,327.61

RAPT Therapeutics Insider Trading History Chart

RAPT Therapeutics Share Price & Price History

$21.04
▼ -1.07 (-4.84%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
April 30th is approaching, are you prepared?
A new president’s policies always influence key stocks.
Here’s where top billionaires are investing.
pixel

RAPT Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2021William HoInsiderSell1,000$22.66$22,660.00
3/15/2021William HoInsiderSell1,000$21.91$21,910.0065,445  
3/1/2021William HoInsiderSell1,000$18.60$18,600.0066,445  
2/16/2021William HoInsiderSell1,000$21.81$21,810.00  
2/1/2021William HoInsiderSell1,000$19.99$19,990.0066,414  
1/15/2021William HoInsiderSell1,000$21.05$21,050.0068,245  
1/6/2021Dirk G BrockstedtInsiderSell1,179$19.68$23,202.7218,735  
1/4/2021William HoInsiderSell1,000$19.75$19,750.0069,189  
12/15/2020William HoInsiderSell1,000$24.55$24,550.0070,209  
12/1/2020William HoInsiderSell1,000$21.83$21,830.0070,938  
11/19/2020Wendye RobbinsDirectorBuy500$16.08$8,040.005,100  
11/16/2020William HoInsiderSell1,000$20.25$20,250.0067,414  
11/2/2020Dirk G. BrockstedtinsiderSell1,910$28.06$53,594.6064,058  
11/2/2020Karen C. LamVPSell2,022$28.14$56,899.08  
10/15/2020William HoInsiderSell1,000$35.76$35,760.0065,058  
10/12/2020Brian Russell WongCEOSell20,000$40.05$801,000.00147,000  
10/12/2020William HoInsiderSell2,000$40.20$80,400.0066,058  
10/1/2020William HoInsiderSell1,000$31.18$31,180.0068,058  
9/28/2020Wendye RobbinsDirectorBuy500$28.70$14,350.006,350  
9/24/2020Wendye RobbinsDirectorBuy200$28.00$5,600.005,750  
9/23/2020Brian Russell WongCEOBuy2,000$30.06$60,120.00
9/22/2020Peter SvennilsonDirectorSell608,000$30.85$18,756,800.005,750  
9/15/2020William HoInsiderSell1,000$36.14$36,140.0066,858  
9/1/2020William HoInsiderSell1,000$26.24$26,240.0067,858  
8/17/2020William HoInsiderSell1,000$24.76$24,760.0068,858  
8/3/2020William HoInsiderSell1,000$21.54$21,540.0069,858  
7/24/2020Wendye RobbinsDirectorBuy900$22.47$20,223.005,050  
7/15/2020William HoInsiderSell1,000$28.76$28,760.0070,858  
7/1/2020Wendye RobbinsDirectorBuy2,600$26.01$67,626.003,550  
7/1/2020William HoInsiderSell1,000$28.61$28,610.0071,858  
6/29/2020Wendye RobbinsDirectorBuy1,600$25.77$41,232.003,550  
6/25/2020Karen C LamVPSell875$35.00$30,625.0012,735  
6/25/2020Michael F GiordanoDirectorSell19,013$33.37$634,463.8110,069  
6/15/2020William HoInsiderSell1,000$20.95$20,950.0072,858  
6/1/2020William HoInsiderSell1,000$18.50$18,500.0073,858  
5/22/2020William HoInsiderSell7,500$18.02$135,150.00  
5/15/2020Dirk G. BrockstedtInsiderSell9,877$15.00$148,155.00  
5/7/2020Karen C. LamVPSell1,831$15.40$28,197.40  
11/4/2019Brian Russell WongCEOBuy25,000$14.49$362,250.00
11/4/2019Group Ii Lp ColumnMajor ShareholderBuy625,000$14.49$9,056,250.00
11/4/2019Wendye RobbinsDirectorBuy1,600$14.49$23,184.00
See Full Table

SEC Filings (Institutional Ownership Changes) for RAPT Therapeutics (NASDAQ:RAPT)

65.02% of RAPT Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

RAPT Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
3/12/2021DekaBank Deutsche Girozentrale8,000$0.16M0.0%N/A0.033%
2/19/2021JPMorgan Chase & Co.12,700$0.25M0.0%+54.2%0.052%
2/17/2021Voloridge Investment Management LLC18,319$0.36M0.0%N/A0.075%
2/16/2021Squarepoint Ops LLC28,057$0.55M0.0%N/A0.114%
2/16/2021Nuveen Asset Management LLC43,882$0.87M0.0%+1.1%0.179%
2/16/2021Price T Rowe Associates Inc. MD2,585,484$51.06M0.0%-1.6%10.529%
2/16/2021ExodusPoint Capital Management LP25,797$0.51M0.0%+52.4%0.105%
2/16/2021Acuta Capital Partners LLC209,600$4.14M1.1%-12.7%0.854%
2/16/2021Charles Schwab Investment Management Inc.66,345$1.31M0.0%+1.4%0.270%
2/12/2021Credit Suisse AG10,391$0.21M0.0%N/A0.042%
2/12/2021Virtus ETF Advisers LLC12,155$0.24M0.1%-15.1%0.050%
2/11/2021Northern Trust Corp150,793$2.98M0.0%+1.6%0.614%
2/11/2021Citigroup Inc.3,508$69K0.0%+565.7%0.014%
2/10/2021Rhumbline Advisers11,200$0.22M0.0%+12.4%0.046%
2/10/2021Renaissance Technologies LLC11,100$0.22M0.0%N/A0.045%
2/10/2021QS Investors LLC16,400$0.32M0.0%N/A0.067%
2/9/2021Wells Fargo & Company MN30,227$0.60M0.0%-39.5%0.123%
2/9/2021Bank of New York Mellon Corp46,776$0.93M0.0%+57.2%0.190%
2/5/2021BlackRock Inc.1,383,981$27.34M0.0%+16.4%5.636%
2/5/2021Swiss National Bank36,000$0.71M0.0%N/A0.147%
2/5/2021William Marsh Rice University14,251$0.28M0.2%N/A0.058%
2/4/2021State of Wisconsin Investment Board15,800$0.31M0.0%-11.2%0.064%
1/21/2021Regents of The University of California1,122,237$22.16M3.2%-18.7%4.570%
12/9/2020Pentwater Capital Management LP40,000$1.29M0.0%+9.6%0.163%
11/17/2020Schonfeld Strategic Advisors LLC249,531$8.04M0.2%+339.8%1.016%
11/17/2020Logos Global Management LP31,100$1M0.1%-79.9%0.127%
11/16/2020ExodusPoint Capital Management LP16,932$0.55M0.0%N/A0.069%
11/13/2020Morgan Stanley2,012$65K0.0%-74.6%0.008%
11/13/2020Charles Schwab Investment Management Inc.65,397$2.11M0.0%+26.4%0.267%
11/13/2020Virtus ETF Advisers LLC14,317$0.46M0.2%-12.0%0.059%
11/12/2020JPMorgan Chase & Co.8,234$0.23M0.0%-71.2%0.034%
11/12/2020Arrowstreet Capital Limited Partnership11,685$0.38M0.0%N/A0.048%
11/10/2020State Street Corp186,328$6M0.0%+4.7%0.761%
11/10/2020TD Asset Management Inc.57,970$1.87M0.0%+116.5%0.237%
11/9/2020Caas Capital Management LP24,489$0.79M0.0%N/A0.100%
11/9/2020The Manufacturers Life Insurance Company6,960$0.22M0.0%N/A0.028%
11/9/2020Victory Capital Management Inc.63,640$2.05M0.0%+80.0%0.260%
11/6/2020BlackRock Inc.1,189,443$38.30M0.0%+4.1%4.861%
11/5/2020California Public Employees Retirement System24,977$0.80M0.0%+2.9%0.102%
11/5/2020Wells Fargo & Company MN49,975$1.61M0.0%+17.9%0.204%
11/4/2020Svennilson Peter5,630,497$181.30M14.8%-16.9%23.011%
10/27/2020Parallel Advisors LLC4,909$0.16M0.0%+9.8%0.020%
10/27/2020Portland Ltd16,830$0.54M1.2%N/A0.069%
10/21/2020Regents of The University of California1,380,704$44.46M6.2%-12.2%5.643%
9/15/2020Schonfeld Strategic Advisors LLC56,742$1.65M0.0%N/A0.232%
8/25/2020Nuveen Asset Management LLC47,996$1.39M0.0%N/A0.196%
8/20/2020Charles Schwab Investment Management Inc.51,756$1.50M0.0%+74.7%0.212%
8/17/2020Jane Street Group LLC9,847$0.29M0.0%N/A0.040%
8/14/2020Bank of America Corp DE22,870$0.66M0.0%+3,870.5%0.094%
8/14/2020Logos Global Management LP155,000$4.50M0.9%N/A0.636%
8/13/2020TD Asset Management Inc.26,770$0.78M0.0%+70.5%0.110%
8/12/2020American International Group Inc.6,710$0.20M0.0%+537.8%0.028%
8/12/2020Goldman Sachs Group Inc.88,343$2.56M0.0%N/A0.362%
8/12/2020Bank of New York Mellon Corp29,499$0.86M0.0%N/A0.121%
8/12/2020California Public Employees Retirement System24,277$0.71M0.0%N/A0.100%
8/10/2020First Mercantile Trust Co.3,218$93K0.0%N/A0.013%
8/7/2020New York State Common Retirement Fund10,100$0.29M0.0%+676.9%0.041%
8/6/2020Asymmetry Capital Management L.P.34,652$1.01M0.8%N/A0.142%
8/5/2020Ameritas Investment Partners Inc.969$28K0.0%+617.8%0.004%
8/5/2020Virtus ETF Advisers LLC16,274$0.47M0.2%N/A0.067%
7/31/2020UBS Group AG15,564$0.45M0.0%+880.1%0.064%
7/23/2020Regents of The University of California1,572,237$45.63M6.4%N/A6.450%
7/20/2020SG Americas Securities LLC5,937$0.17M0.0%N/A0.024%
7/16/2020Parallel Advisors LLC4,470$0.13M0.0%N/A0.018%
6/19/2020State Street Corp24,133$0.51M0.0%+146.3%0.099%
5/15/2020Pentwater Capital Management LP35,271$0.75M0.0%N/A0.145%
5/15/2020Squarepoint Ops LLC18,624$0.40M0.0%N/A0.077%
5/15/2020Luminus Management LLC267,270$5.69M0.6%N/A1.098%
5/14/2020Wells Fargo & Company MN13,363$0.28M0.0%+38.5%0.055%
5/14/2020Geode Capital Management LLC70,552$1.50M0.0%+138.5%0.290%
5/14/2020Wellington Management Group LLP1,192,121$25.36M0.0%N/A4.899%
5/12/2020Victory Capital Management Inc.121,063$2.58M0.0%+9,880.5%0.498%
5/11/2020State Street Corp24,133$0.51M0.0%+146.3%0.099%
5/6/2020New York State Common Retirement Fund1,300$28K0.0%-64.9%0.005%
5/5/2020Aspiriant LLC10,000$0.21M0.0%N/A0.041%
5/4/2020Victory Capital Management Inc.121,063$2.58M0.0%+9,880.5%0.498%
5/1/2020BlackRock Inc.539,471$11.48M0.0%+814.9%2.217%
5/1/2020UBS Group AG1,588$34K0.0%-45.9%0.007%
3/3/2020Norges Bank30,000$0.83M0.0%N/A0.137%
2/20/2020Geode Capital Management LLC29,586$0.82M0.0%N/A0.136%
2/14/2020UBS Group AG2,934$81K0.0%N/A0.013%
2/12/2020Svennilson Peter6,777,151$187.12M22.3%N/A31.041%
2/11/2020TD Asset Management Inc.12,888$0.36M0.0%N/A0.061%
2/7/2020Tower Research Capital LLC TRC934$26K0.0%N/A0.004%
2/7/2020Charles Schwab Investment Management Inc.16,197$0.45M0.0%N/A0.076%
2/6/2020Victory Capital Management Inc.1,213$54K0.0%N/A0.006%
2/6/2020State Street Corp9,800$0.27M0.0%N/A0.046%
2/5/2020American International Group Inc.974$27K0.0%N/A0.005%
2/5/2020New York State Common Retirement Fund3,700$0.10M0.0%N/A0.017%
Data available starting January 2016

See Full Table
RAPT Therapeutics logo
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead oncology drug candidate is FLX475, an oral small molecule C-C motif chemokine receptor 4 antagonist that is in the Phase 2 portion of a Phase 1/2 clinical trial to evaluate as a monotherapy and in combination with pembrolizumab in patients with various types of charged tumors. The company's lead inflammation drug candidate is RPT193 to selectively inhibit the migration of type 2 T helper cells into allergically-inflamed tissues. It is also pursuing a range of targets, including general control nonderepressible 2 and hematopoietic progenitor kinase 1 that are in the discovery stage of development. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $21.04
$20.22
$22.41

50 Day Range

MA: $20.79
$16.00
$24.46

52 Week Range

Now: $21.04
$13.35
$41.86

Volume

151,239 shs

Average Volume

156,830 shs

Market Capitalization

$523.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of RAPT Therapeutics?

RAPT Therapeutics' top insider shareholders include:
  1. Brian Russell Wong (CEO)
  2. William Ho (Insider)
  3. Dirk G Brockstedt (Insider)
  4. Dirk G Brockstedt (Insider)
  5. Karen C Lam (VP)
  6. Michael F Giordano (Director)
  7. Wendye Robbins (Director)
  8. Peter Svennilson (Director)
  9. Group Ii Lp Column (Major Shareholder)
  10. Karen C Lam (VP)
100X Gains On Tap as Under-the-Radar Green-Tech Stock Soars
Searching for the next 1,000% stock winner? Look no further than key Green-Techs that are driving the EV, Solar & 5G booms. Silver is the #1 element in the Green Energy Revolution & we’ve found the top silver gem – undiscovered at 10-cents per share – that’s fueling the path to a carbon-free world.
Get the details here...
pixel